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INTRODUCTION 
In  Northern  Ireland  cancers  of  the  colorectum,  lung  and 
breast account for 30% of all cancer cases and about 40% 
of  cancers  deaths.1 The  diagnosis,  treatment  and  care  of 
patients with these diseases use significant resources, so any 
change in numbers is particularly relevant to service planners.   
Projections  can  also  identify  need  for  health  promotion 
initiatives to reduce risk in a population.
The predicted changes to the population structure, of increases 
in the proportion of older people,2 will result in a rise in the 
incidence of cancer, a disease more common in older people.   
Disease risk factors are the other major driver for change.
In  Northern  Ireland,  accurate  cancer  incidence  data  is 
available only since 1993; death information is available for 
a longer period.  For lung cancer, the greatest cause of cancer 
mortality, numbers of deaths are close to incidence levels, due 
to poor survival rates. Deaths therefore form the basis of this 
analysis, which aims to identify for planners, future demands 
on services and highlight areas for disease prevention.  
METHODOLOGY
Annual age specific death rates for the period 1984-2004 were 
calculated using official mortality figures from the General 
Register Office for Northern Ireland  3 and mid-year population 
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ABSTRACT
Background: An ageing population has service planners concerned about future levels of disease which are age dependent. 
Predictions of mortality for colorectal, lung and breast cancers, which account for 30% of cancer cases and 40% of cancers 
deaths, were calculated for 2010 and 2015, based on trends in death rates and the predicted change in the demography 
of the Northern Ireland population.
Methods: The US National Cancer Institute’s “Joinpoint” program was used to check for structural breaks in the time 
series of cancer death rates from 1984 to 2004. The prediction models applied to the data allowed variations in trends 
across age groups to be taken into account.  A linear model was used for increasing or constant trends and a log linear 
model was used where the trend was decreasing. The models assume the number of deaths in each stratum, defined by 
age-sex and time-period, is Poisson distributed, with the average value determined by a log or linear function.
Results:  Recent trends in rates of cancers studied were downwards except for female lung. Predictions include decreased 
colorectal cancer deaths in females and lung cancer deaths in males. In females, lung cancer deaths are predicted to more 
than double by the year 2015 (473 deaths), based on the 1984 level. Colorectal death rates in males are predicted to drop, 
but the number of deaths will increase by more than 10%, due to demographic change. Numbers of breast cancer deaths 
are likely to rise slightly, despite falling age standardised death rates, due to an ageing population.
Conclusions: This work has provided estimates of early future trends, useful to service planners, and highlights the need 
for tobacco control, to reduce numbers of lung cancer deaths in females. The recently announced control of environmental 
tobacco legislation is one welcome development which should reduce lung cancer mortality in Northern Ireland.
estimates, provided by the Northern Ireland Statistics and 
Research Agency. The age groups used were 0-44, 45-49, 50-
54, 55-59, 60-64, 65-69, 70-74, 75-79, 80-84 and 85+.
Linear and log-linear regression models have been found to 
be the most practical means by which relatively short-term 
future patterns of cancer mortality can be estimated.4  The use 
of classical age-period-cohort modelling techniques may well 
improve the “fit” of the model (albeit at the expense of extra 
degrees of freedom), but the random variation associated with 
parameter estimates can lead to erratic projections.5
In this study, the identification of the most recent trends was 
assisted through inflexion point regression analysis of the data, 
using the US National Cancer Institute’s (NCI) “Joinpoint” 
program (Version 3.0),6 a Windows-based statistical package 
used to analyse modelled data where several trend-lines are 
connected together at “joinpoints”.  The software takes trend 
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data (in this case age-standardised cancer mortality rates) 
and fits the simplest inflexion model that the data allows. The 
programme starts with the minimum number of joinpoints 
(e.g. 0 joinpoints, which is a straight line) and tests whether 
more  joinpoints  are  statistically  significant  and  must  be 
added to the model, thus enabling the user to test whether an 
apparent change in trend is statistically significant.7
Existing incidence-based modelling tools developed by Dyba 
and  Hakulinen  from  the  Finnish  Cancer  Registry,8, 9 were 
used to predict cancer mortality, on the principle that the 
underlying theoretical assumptions apply equally to incidence 
and mortality data.  These assumptions are:
1.  Future  cancer  death  trends  can  be  modelled  by 
extrapolating a historic trend.
2.  The lengths of the data time-series permit the estimation 
of models that take account of age-sex group specific 
trends.
3.  The numbers of deaths in each age-sex-timeperiod stratum 
are Poisson distributed.
4.  Where  historic  trends  in  standardized  deaths  are 
decreasing, a log–linear model is appropriate to estimate 
the  average  rate,  whereas  a  linear  model  is  used  for 
increasing or constant trends to avoid explosive growth.
Let        be  the  mortality  rate  for  age  group  i  in
period t, given nit, the number of persons and cit the number of 
deaths. Let αi, ßi be the model parameters for age group i.
A description of the models applied in various scenarios is 
given below (Table I).
Model 4 is an alternative to model 3 and may be used where 
model 3 gives large confidence intervals for predictions or 
unrealistic trends in some age groups. It proves useful for the 
case, common in practice, where larger baseline death rates 
give larger trends over time and this functional form explicitly 
keeps the ratio between baseline rate and trend constant across 
age groups.
The  95%  predicted  confidence  intervals  generated  in 
the  output  analysis  are  used  to  account  not  only  for  the 
uncertainty in the historical data but also for the randomness 
in the numbers of deaths themselves.  Consequently the “95% 
prediction intervals” reported here may seem quite large.
Mit  cit
nit =
Estimates of the parameters for each of the models were 
calculated  using  the  STATA  8.0  Statistical  package  for 
Windows.10 
The Pearson goodness-of-fit test statistic was used to test the 
adequacy of the model and is given by: 
                                              
where N is the number of age-groups and T the length of 
the time series. This statistic indicates the fit of the data to a 
Poisson distribution.
The ‘deviance’ is defined to be twice the difference between 
the maximum achievable log likelihood and the log likelihood 
at  the  maximum  likelihood  estimates  of  the  regression 
parameters. It forms a useful basis for choosing between 
models  when  two  models  give  a  reasonable  fit.  A  log-
likelihood ratio test of the form D=Da -Db, where Da, Db are 
the deviances of fit of models a and b respectively, is used to 
choose between models.  D follows a chi-square distribution, 
with degrees of freedom equal to the difference in degrees of 
freedom between models a and b, when both models describe 
the data well.
As  the  number  of  parameters  increases,  the  model  will 
inevitably  improve.  To  enable  selection  of  the  most 
parsimonious model, the Akaike Information Criterion (AIC), 
which penalises the addition of extra parameters was used.   
Generally, where the log-likelihood test indicated either of 
two models was acceptable, the more parsimonious model 
was chosen.
Once  the  best  model  was  chosen,  2004-based  population 
projections based on assumptions regarding fertility, mortality 
and net migration, for N. Ireland  2 were applied to predict 
cancer deaths by gender and site (error range in brackets).
RESULTS
Joinpoint analysis of mortality rates (1984-2004) revealed 
significant downward trends in: colorectal cancer in males and 
females; lung cancer in males and breast cancer in females 
(Fig 1).  A significant upward trend was demonstrated for 
female lung cancer. No change in trend was detected over 
the period (1984-2004) for any site, i.e. a joinpoint model 
with zero joins (JP0) was shown to best represent each time 
series.
∑∑ χ2 = 
N     T
i = l  t = l
Mit – Mit
Mit
Table  I
Outline of Models
Data Trend  Decreasing  Decreasing  Increasing  Increasing
Significant variation  No  Yes  Yes  Yes
in trend across
age groups
Most appropriate  In(Mit) = αi + βt  In(Mit) = αi + βit   Mit = αi + βit  Mit = αi + βit
model  Model 1  Model 2  Model 3
  where
       
=
αj
βj
αi
βi
for any two
age-groups i, j
Model 4 
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Fig 1A. Trends in Age-Standardised Mortality Rates* (3-year moving averages)
* rates standardised to N. Ireland population projection 2005
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Fig 2: Trends in Age-Specific Mortality Rates for Female Lung Cancer (3-year moving averages)
0
50
100
150
200
250
1984 1986 1988 1990 1992 1994 1996 1998 2000 2002 2004
Year
M
o
r
t
a
l
i
t
y
 
r
a
t
e
s
 
(
p
e
r
 
1
0
0
,
0
0
0
)
 65-69
 70-74
 75-79
 80-84
>85
0-64
Fig 1B.
www.ums.ac.uk©  The Ulster Medical Society, 2006.
Modelling predictions of cancer deaths in Northern Ireland 123
www.ums.ac.uk
Table  II
Diagnostic tests by model and cancer site
                                Pearsons’s
Site  Model  χ2  d.f.  Prob
Colorectal (male)  Log - single trend (1)  201  199  0.448
Lung (Male)  Log - multiple trend (2)  192  190  0.438
Colorectal (Female)  Log - single trend (1)  193  199  0.602
Lung (Female)  Linear - multiple trend (4)  265  190  0.000
Breast  Log - multiple trend (2)  191  190  0.464
Variations in mortality rate trends across age-groups were 
also observed for some sites. Since the female lung cancer 
mortality series (1984-2004) was the only one to demonstrate 
a significant increasing trend, further scrutiny of age-specific 
rates for this site was of particular interest, to determine which 
age-groups were driving this increase (see Fig 2).
Joinpoint analysis of age-specific mortality rates for female 
lung cancer revealed no significant trend among females aged 
0-64yrs (combined).  Significant upward trends were observed 
within each of the other age-groups, but most notably among 
females aged 75-79 years [single continuous increase detected 
(1987-2004)] and 85+years [increases detected (1984-1988), 
(1992-2001) & (2001-2004)].
According  to  the  principles  outlined  in  the  methods,  the 
appropriate model was selected for each site.  Table II details 
the models selected. All models provide a reasonable fit to the 
data, except for female lung cancer, where the model selected 
is very poor.
Colorectal cancer death rates are predicted to fall in males and 
females, but numbers in males may rise due to demographic 
pressures  (see Table  III).  This  reflects  the  more  marked 
historic decreasing trend in females, counterbalancing the 
pressure due to an ageing population.
Lung cancer deaths fell in males but increased in females 
between 1984 and 2004. The prediction follows on the trend 
for males so that despite demographic change, deaths from 
lung cancer in males do not rise.  In females, however death 
rates (2015) are predicted to more than double, based on 
the 1985 level, due to a rising rate of disease and an ageing 
population.
Breast cancer death rates fell between 1984 and 2004, with 
a more rapid decline noticed after 1997. The model predicts 
slightly  increasing  deaths  from  breast  cancer  –  despite 
decreasing age standardized death rates. This is driven by the 
ageing population.
DISCUSSION
Trends based on incidence are preferable to those based on 
deaths, as death trends are affected by changes in survival 
as well as changes in incidence. Also, deaths data are less 
rigorously checked compared to cancer incidence data.  The 
accuracy of trend predictions however depends on the length 
of the time series examined and hence deaths are preferred 
in this instance.
Predictions based on historical data do not take into account 
future improvements in treatment or changes in the way health 
services are organised, but only extrapolate mortality patterns 
from a range of observations.  These predictions also assume 
that current trends will remain unchanged in the future. As 
the predictions calculated here are only for up to ten years, 
such effects are likely to be minimal. However, the recent 
fall in breast cancer mortality, with documented significant 
survival improvements in the population studied  1 may not 
have been given enough weight in the model used. Deaths 
from breast cancer are falling rapidly due to earlier diagnosis 
and advances in treatment and the predicted increase in deaths 
may not materialise.
Generally, the models provide a very good fit to the data. 
However, the model of female lung cancer mortality trend is 
inadequate.  Both male and female lung cancer predictions 
could be improved upon by the inclusion of information on 
smoking, as about 90% of lung cancers are directly attributed 
to tobacco, with very low levels of background disease.11
The biggest determinant of the level of cancer in the short 
and long term is the pressure of an ageing population, as 
cancer is a disease more common in older people. While 
age standardised rates may decrease, due to public health 
initiatives,  the  absolute  number  of  cases  diagnosed  and 
requiring treatment is likely to rise. Service planners must 
take this into consideration now, to ensure adequate service 
provision in the future. As tobacco is causally implicated in 
around a third of all cancers,11 significant efforts made now, 
in tobacco control, could counterbalance the pressures due to 
demographic change and halt the predicted rise in cancers.
Trends in lung cancer mortality can be affected by smoking 
patterns 20-30 years previously, but the cessation of smoking, 
even well into middle age, can avoid most of the subsequent 
risk of lung cancer; stopping before middle age avoids more 
than  90%  of  the  risk  attributable  to  tobacco.11  If  current 
smokers can succeed in giving up the habit, mortality from 
lung cancer in the near future could be substantially reduced.11 
The  recently  announced  environmental  tobacco  control 
legislation for N. Ireland is a welcome initiative which should 
reduce lung cancer mortality.
It is planned to introduce colorectal cancer screening in N. 
Ireland within the next ten years.  This should further reduce 
deaths from colorectal cancer below that predicted by the 
model.  Service planners should note that disease levels will ©  The Ulster Medical Society, 2006.
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Year
Males Females
Colorectal Lung Colorectal Lung Breast
N r N r n r N r n r
A
C
T
U
A
L
1985 222 36 572 89 237 33 181 24 307 44
1990 214 32 524 78 228 30 242 31 295 40
1995 236 33 507 71 219 28 272 34 327 42
2000 205 27 494 65 221 27 346 42 286 35
P
R
E
D
I
C
T
E
D
2010 237 25 525 55 187 20 404 43 313 33
(201, 273) (21, 29) (472, 578) (50, 61) (156, 218) (16, 23) (356, 453) (38, 48) (271, 354) (29, 37)
2015 251 23 554 51 183 18 473 46 328 32
(210, 291) (19, 27) (493, 615) (45, 56) (150, 215) (14, 21) (415, 530) (40, 52) (281, 376) (27, 36)
Table  III
Numbers  1 (n) and rates  2 (r) (per 100,000) of cancer deaths by gender and site (error range in brackets)
1 predicted deaths calculated by applying predicted age-specific rates to predicted populations
2 rates standardised to N. Ireland population projection 2005
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increase due to enhanced detection during the early prevalence 
round of screening.
Exercise has been shown to reduce colorectal cancer,12 while 
obesity in postmenopausal females increases the risk of breast 
cancer.13  While changes in these lifestyle factors are unlikely 
to affect deaths in the short timescale of this study, they will 
have serious implications in the longer term. Initiatives to 
increase exercise, increase fruit/vegetable consumption and 
tackle obesity need to be put in place now.
Possible advances in treatment within the next ten years have 
not been taken into account. Also specialisation of cancer 
services which has been shown to reduce mortality  14-16 is 
ongoing in N. Ireland, since the publication of the Campbell 
Report.17
This work has several limitations but it has allowed service 
planners  to  explore  the  issues  based  on  predictions  in  a 
developing and costly area of care. It has also highlighted the 
need to target tobacco control, especially among females.
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